Acutus Medical Stock News

In the last trading session, 2.3 million Acutus Medical Inc. (NASDAQ:AFIB) shares changed hands as the companys beta touched 0. With the companys per share price at $3.72 changed hands at $0.08 or 2.20% during last session, the market valuation stood at $235.55M. AFIBs last price was a discount, traded about -823.39% off its 52-week Is Acutus Medical Inc. (NASDAQ: AFIB) Stock Set To Rise More? Read More »

The stock price of Acutus Medical Inc (NASDAQ: AFIB) fell over 25% pre-market today. This is why it happened.

Acutus Medical's (AFIB) CEO Vince Burgess on Q3 2021 Results - Earnings Call Transcript

Acutus Medical (NASDAQ:AFIB) reported its Q3 earnings results on Thursday, November 11, 2021 at 04:01 PM. Here's what investors need to know about the announcement.

Acutus Medical, Inc. (AFIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Acutus Medical, Inc. (AFIB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength

Acutus Medical, Inc.'s superior contactless mapping technology threatens to change and expand the ablation treatment paradigm for cardiac arrhythmias. However, the company's launch has been disappoint

Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q2 2021 Results - Earnings Call Transcript

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 11.00% and 1.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price

CARLSBAD, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”) today announced the pricing of its underwritten public offering of 5,500,000 shares of its common

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,00

CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhy

The FDA has signed off Investigational Device Exemption (IDE) AcQBlate AF trial for Acutus Medical Inc's (NASDAQ: AFIB) AcQBlate Force Sensing Ablation Catheter and System. The trial is expected t

CARLSBAD, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed a